Compass Cuts MRK Stake by 3.8%, Worth $72M

Compass Capital Management Inc., a significant investor in Merck & Co., Inc. (NYSE:MRK), has reduced its stake in shares of the pharmaceutical company by 3.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

The fund owned 567,099 shares of MRK's stock after selling 22,669 shares during the quarter. Merck & Co., Inc. makes up 4.4% of Compass Capital Management Inc.'s holdings, making it the company's 2nd largest position.

Compass Capital Management Inc.'s holdings in Merck & Co., Inc. were worth $72,872,000 as of its most recent filing with the SEC.